Three Strands Recovery Wear
Three Strands Recovery Wear is a technology company.
Three Strands Recovery Wear is a technology company.
Three Strands Recovery Wear is a Winston-Salem, North Carolina-based startup developing the Resilience Bra, a patent-pending post-operative compression bra designed for women recovering from breast cancer surgeries like mastectomies, reconstructions, and reductions.[1][2][3] It addresses critical recovery challenges by providing superior comfort, drain management pockets, adjustable compression bands, and soft fabric to reduce complications during the 0-8 week post-op period, serving patients in hospitals, mastectomy boutiques, and at home.[3][4][6] The company has gained traction through pilots in North Carolina hospitals, partnerships with top surgeons like Dr. Lisa David at Atrium Health Wake Forest Baptist, wholesale with the American Cancer Society's TLC program starting in 2024, and availability in ten states including Duke Cancer Center.[2][3][4] Recently securing investment from the WSPR Fund, it shows strong growth momentum from bootstrapped origins to clinical adoption.[5][7]
Founded in 2018 (or 2019 per some accounts) by Leah Wyrick as a freshman at Wake Forest University, the company stemmed directly from her mother Nancy's stage 3 breast cancer diagnosis, mastectomy, and painful recovery complications with inadequate post-surgical bras and drain management.[1][2][4] Wyrick, then 18 and majoring in Business and Enterprise Management, partnered with plastic surgeon Dr. Samuel Roy in Salisbury, NC, and iterated the Resilience Bra based on feedback from over 500 patients and surgeons via Winston-Salem's medical community and Wake Forest's Center for Entrepreneurship.[1][3][4] Balancing full-time studies, she bootstrapped the business with accelerator support from Winston Starts, graduating in 2022 to run it full-time alongside her mother; early pilots during Breast Cancer Awareness Month marked pivotal traction.[2][4][7]
Three Strands rides the intersection of medtech wearables and personalized cancer care, addressing a gap in post-surgical support amid rising breast cancer diagnoses (affecting millions annually) and demand for complication-reducing devices.[2][4][6] Timing aligns with accelerated adoption of patient-centric biotech post-COVID, bolstered by local NC ecosystems like Wake Forest and Winston-Salem accelerators that fast-track hardware from idea to pilots.[2][4][7] Market forces favoring it include insurance coverage for recovery aids, hospital shifts to comfortable alternatives, and Breast Cancer Awareness-driven visibility; it influences the ecosystem by setting standards for accessible, feedback-driven medwear, potentially expanding to other surgical recoveries.[3][5]
With fresh WSPR Fund investment, Three Strands is poised for national hospital expansion, more wholesale partnerships, and possible FDA pursuits or line extensions for diverse surgeries.[5] Trends like AI-optimized wearables and value-based care will amplify its trajectory, evolving from a mother's mission to a scalable medtech leader shaping recovery standards. This resilience mirrors the bra itself—targeted, durable, and transformative for patients.